StonvexLoading…
StonvexStonvexStonvexCore line items from HLT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q3 2026 (Est.) Expected 2026-07-21 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $3.35B | $2.94B | $12.04B | $8.95B | $5.83B |
Operating Income | Not available | $678.00M | $2.69B | $2.09B | $1.31B |
Net Income | Not available | $385.00M | $1.46B | $1.16B | $740.00M |
EPS (Diluted) | $2.29 | $1.66 | $6.12 | $4.84 | $3.07 |
Total Assets | Not available | $16.39B | $16.77B | $16.64B | $15.90B |
Total Liabilities | Not available | $22.25B | $22.12B | $21.53B | $20.45B |
Cash & Equivalents | Not available | $564.00M | $918.00M | $1.06B | $371.00M |
Free Cash Flow OCF − CapEx | Not available | $609.00M | $2.03B | $1.85B | $1.07B |
Shares Outstanding | Not available | 228.33M | 230.43M | 233.05M | 235.79M |